CMO Tal Zaks bids Mod­er­na a sur­prise adieu as biotech projects $18.4B in rev­enue, plots post-Covid ex­pan­sion

How do you ex­it a com­pa­ny af­ter six years in style? De­vel­op­ing one of the most lu­cra­tive and life-sav­ing prod­ucts in phar­ma his­to­ry is prob­a­bly not the worst way to go.

Tal Zaks, Mod­er­na’s CMO since 2015, will leave the mR­NA biotech in Sep­tem­ber, the biotech dis­closed in their an­nu­al re­port this morn­ing. The com­pa­ny has al­ready re­tained the re­cruit­ment firm Rus­sell Reynolds to find a re­place­ment.

“Tal joined us when we were a pre-clin­i­cal com­pa­ny. His guid­ance and con­tri­bu­tions were im­por­tant in help­ing Mod­er­na get to where we are to­day,” CEO Stéphane Ban­cel said in a state­ment. “Through his lead­er­ship over the past year in Mod­er­na’s re­sponse to the COVID-19 pan­dem­ic, Tal has made a con­tri­bu­tion that ex­tends be­yond Mod­er­na to all of so­ci­ety. I have en­joyed hav­ing him as my part­ner and wish him all the best as he em­barks on the next leg of his ca­reer.”

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN